Literature DB >> 8959325

Insulin promotion of colon tumors in rats.

T T Tran1, A Medline, W R Bruce.   

Abstract

McKeown-Eyssen and Giovannucci have proposed a mechanism for colon carcinogenesis based on the similarity of the risk factors for colorectal cancer and non-insulin-dependent diabetes. They note that diets high in fat and energy and low in complex carbohydrates and a sedentary lifestyle lead to insulin resistance and hyperinsulinemia and propose that the hyperinsulinemia promotes colon carcinogenesis. In this study, we directly tested for a promoting effect of insulin on colon carcinogenesis in F344 rats. After azoxymethane initiation and injections of insulin given 5 times/week for 17 weeks, the fraction of rats with colon tumors was greater in rats receiving insulin than in rats receiving saline (79 versus 50%, respectively; P < 0.05 for tumors with maximum diameters > or = 2 mm), and the average number of tumors/ rat was also greater (2.00 versus 0.73; P < 0.001). There was no effect on body weight. Our results demonstrate that insulin in a colon tumor promoter in this rat model and support the proposed mechanism linking lifestyle factors and colon carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8959325

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  83 in total

Review 1.  Insulin X10 revisited: a super-mitogenic insulin analogue.

Authors:  B F Hansen; P Kurtzhals; A B Jensen; A Dejgaard; D Russell-Jones
Journal:  Diabetologia       Date:  2011-06-03       Impact factor: 10.122

2.  Associations between obesity and cancer: the role of fatty acid synthase.

Authors:  Dingzhi Wang; Raymond N Dubois
Journal:  J Natl Cancer Inst       Date:  2012-02-06       Impact factor: 13.506

3.  Is diabetes a risk factor for colorectal cancer?

Authors:  Hamed Khalili; Andrew T Chan
Journal:  Dig Dis Sci       Date:  2012-04-25       Impact factor: 3.199

Review 4.  Diabetes mellitus is an independent risk factor for colorectal cancer.

Authors:  Lei Sun; Shiying Yu
Journal:  Dig Dis Sci       Date:  2012-06       Impact factor: 3.199

5.  Is there an estrogenic component in the metabolic syndrome?

Authors:  S Starcke; G Vollmer
Journal:  Genes Nutr       Date:  2006-09       Impact factor: 5.523

6.  Elevated HbA1c is an independent predictor of aggressive clinical behavior in patients with colorectal cancer: a case-control study.

Authors:  Ali A Siddiqui; Stuart J Spechler; Sergio Huerta; Serag Dredar; Bertis B Little; Byron Cryer
Journal:  Dig Dis Sci       Date:  2008-04-12       Impact factor: 3.199

7.  Insulin therapy and colorectal adenomas in patients with diabetes mellitus.

Authors:  Patricia Wong; Mark G Weiner; Wei-Ting Hwang; Yu-Xiao Yang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-08-09       Impact factor: 4.254

8.  Type 2 diabetes and the risk of colorectal adenomas: Black Women's Health Study.

Authors:  Chiranjeev Dash; Julie R Palmer; Deborah A Boggs; Lynn Rosenberg; Lucile L Adams-Campbell
Journal:  Am J Epidemiol       Date:  2013-10-02       Impact factor: 4.897

9.  Glycemic index, nutrient density, and promotion of aberrant crypt foci in rat colon.

Authors:  D E Corpet; G Peiffer; S Taché
Journal:  Nutr Cancer       Date:  1998       Impact factor: 2.900

10.  Insulin therapy and the risk of colorectal cancer in patients with type 2 diabetes: a meta-analysis of observational studies.

Authors:  Wu-jie Bu; Lei Song; Dan-yi Zhao; Bing Guo; Jing Liu
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.